KABAN, S. M. (2025) “The Relationship between SLC22A16 Gene Polymorphism and Hematological Toxicity in Breast Cancer Patients Receiving Doxorubicin-Based Chemotherapy”, Journal of Endocrinology, Tropical Medicine, and Infectious Disease (JETROMI), 7(1), pp. 27–33. doi: 10.32734/jetromi.v7i1.18520.